# Real-time Identification of the Aberrant Left Hepatic Arterial Territory in the Liver Using Near-infrared Fluorescence Imaging

> **NCT05971069** · NA · COMPLETED · sponsor: **Gangnam Severance Hospital** · enrollment: 50 (actual)

## Conditions studied

- Stomach Neoplasm

## Interventions

- **PROCEDURE:** Group1
- **PROCEDURE:** Group2
- **PROCEDURE:** Group3

## Key facts

- **NCT ID:** NCT05971069
- **Lead sponsor:** Gangnam Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-17
- **Primary completion:** 2023-06-12
- **Final completion:** 2023-06-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05971069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05971069, "Real-time Identification of the Aberrant Left Hepatic Arterial Territory in the Liver Using Near-infrared Fluorescence Imaging". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05971069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*